Detalhe da pesquisa
1.
[Occurrence of acquired factor V inhibitor during antibiotic therapy for a surgical wound infection].
Rinsho Ketsueki
; 59(8): 1007-1011, 2018.
Artigo
em Japonês
| MEDLINE | ID: mdl-30185699
2.
[Relapsed/refractory multiple myeloma with CD138 shedding and formation of extramedullary disease in the common bile duct region presenting as obstructive jaundice].
Rinsho Ketsueki
; 56(8): 1089-95, 2015 Aug.
Artigo
em Japonês
| MEDLINE | ID: mdl-26345572
3.
[Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
Rinsho Ketsueki
; 54(7): 670-4, 2013 Jul.
Artigo
em Japonês
| MEDLINE | ID: mdl-23912352
4.
Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma.
In Vivo
; 34(5): 2821-2828, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871820
5.
Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia.
Ann Hematol
; 93(12): 2081-2, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24863693
6.
Bridging-to-transplant with Azacitidine for Myelodysplastic Syndrome and Acute Myeloid Leukemia, Reduces the Incidence of Acute Graft-versus-host Disease.
Hematol Rep
; 9(2): 7114, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28670436
7.
Bendamustine can severely impair T-cell immunity against cytomegalovirus.
Leuk Lymphoma
; 54(6): 1327-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23072371